Scope
A focused NICE pathway for recognising adrenal insufficiency, organising replacement and sick-day care, and treating adrenal crisis. Adult numerical treatment regimens below apply to people aged 16 years and over; children require the age-specific pathways and specialist input. Cortisol interpretation depends on the assay and clinical context, and suspected crisis follows an emergency pathway rather than routine outpatient testing.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Recognise risk and interpret testing in context
- Consider adrenal insufficiency for unexplained hyperpigmentation or persistent compatible symptoms such as weight loss, salt craving, gastrointestinal symptoms, postural dizziness, weakness or electrolyte disturbance. Hyperpigmentation may be less apparent on black or brown skin; ask about colour change and examine buccal mucosa or scars. [1]
- Do not test for adrenal insufficiency while oral glucocorticoids are at physiological-equivalent doses or higher. For suspected insufficiency from age 1 year, offer cortisol testing at 8–9 am; under 1 year, measure at any time and obtain paediatric endocrine interpretation. [1]
- For initial morning cortisol testing in people aged 16 or over with modern immunoassays, below 150 nmol/L suggests possible insufficiency: refer to endocrinology and consider treatment; acute illness requires the crisis pathway. Values 150–300 are uncertain: consider repeating and seek advice if persistent. Above 300 makes insufficiency very unlikely. [1]
- Wait 4 weeks after intramuscular or intra-articular glucocorticoids before morning cortisol testing. Oral oestrogen can falsely raise cortisol: for planned testing, stop it 6 weeks beforehand with alternative contraception or consideration of transdermal HRT. In suspected crisis, measure cortisol and interpret with oestrogen exposure in mind. [1]
Provide replacement and emergency preparation
- Offer glucocorticoids with mineralocorticoid when needed for primary adrenal insufficiency or congenital adrenal hyperplasia; secondary and tertiary insufficiency need glucocorticoids alone. Do not use parenteral hydrocortisone or a subcutaneous pump for routine daily replacement. [1]
- From age 16, first-choice oral hydrocortisone totals 15–25 mg/day: divide into 2–4 doses for primary insufficiency or CAH and 2–3 for secondary/tertiary insufficiency. For immediate-release treatment, give the larger dose in the morning and individualise to clinical response; CAH may need higher specialist-directed doses. [1]
- Provide 2 or 3 emergency kits for primary or secondary insufficiency. Consider a kit for tertiary insufficiency in adults with a previous crisis and in children under 16. Train patients and carers in use and regular expiry checks. [1]
Escalate treatment during illness in people aged16 and over
- For people aged 16 or over with adrenal insufficiency and significant physiological stress, give at least 40 mg oral hydrocortisone daily in 2–4 doses or at least 10 mg prednisolone daily in 1–2 doses until acute illness or trauma resolves. Avoid prolonged increased dosing. [1]
- For people aged 16 or over already taking prednisolone 10 mg/day or more, additional sick-day glucocorticoid is unnecessary; the total daily dose may be split into 2 equal doses. [1]
- For people aged 16 or over who vomit within 30 minutes of an oral steroid dose, repeat at double the original dose once vomiting settles. If vomiting recurs within 30 minutes, give intramuscular hydrocortisone and arrange emergency-department assessment. [1]
- For people aged 16 or over unable to absorb oral steroids during physiological stress, such as prolonged vomiting or diarrhoea, admit and give hydrocortisone 100 mg intramuscularly or intravenously. [1]
- For hospitalised patients with adrenal insufficiency aged 16 or over with severe illness such as sepsis or requiring intensive care, follow the initial 100 mg dose with hydrocortisone 200 mg IV over 24 hours or 50 mg IM/IV four times daily, and seek endocrine advice. [1]
Treat suspected adrenal crisis immediately
- Consider adrenal crisis in critical illness with hypotension, hyponatraemia, hypoglycaemia, collapse or failure to respond to initial care. In known or high-risk insufficiency, even milder illness with lethargy, confusion, clamminess, feverishness or weakness can signal crisis. [1]
- For suspected adrenal crisis at age 16 or over, give IV or IM hydrocortisone immediately and arrange immediate ambulance transfer to hospital. Intramuscular treatment may be self-administered from an emergency kit. [1]
- For adrenal crisis at age 16 or over, give 1 litre of 0.9% sodium chloride IV over 30 minutes. Frequently monitor blood pressure, heart rate, electrolytes and glucose; continue saline according to haemodynamic and electrolyte status until stable. [1]
- During adrenal crisis at age 16 or over, continue parenteral hydrocortisone until haemodynamic stability and ability to take and absorb oral steroids. Identify and treat the precipitant and involve the endocrine team throughout admission. Children under 16 follow the separately referenced BSPED emergency pathway. [1]
Withdraw exogenous steroids using the correct pathway
- If glucocorticoids are no longer required after more than 4 weeks at age 16 or over, or more than 3 weeks below 16, reduce to a physiological-equivalent dose before considering further taper. The initiating team decides withdrawal; exposure beyond 12 weeks warrants consideration of a slower taper. [1]
- During withdrawal at age 16 or over, consider morning cortisol only after a slower taper when symptoms suggest insufficiency. Below 16, consider testing after the initial taper even without symptoms. Before testing, pause prednisolone 24 hours, hydrocortisone 12 hours or dexamethasone 72 hours, then restart physiological replacement. [1]
- For cortisol testing during steroid withdrawal using modern immunoassays, below 150 nmol/L requires restarting glucocorticoids and endocrine referral;150–300 prompts consideration of repeat testing and advice if persistent; above 300 makes insufficiency very unlikely and permits stopping. These are withdrawal-pathway decisions, not routine crisis management. [1]
Provide pregnancy and long-term support
- Pregnancy care requires an experienced multidisciplinary team and continued replacement. Consider third-trimester dose increases according to symptoms, sodium and postural blood pressure. After birth use sick-day dosing for 48 hours, longer for ongoing physiological stress, then return towards usual/pre-pregnancy dosing. [1]
- Offer specialist follow-up, with under 16s seen at least every 6 months and measured face-to-face annually for dose adjustment. Monitor under- and over-replacement clinically; for primary insufficiency, also assess mineralocorticoid effects and consider renin-guided fludrocortisone adjustment. Do not routinely use cortisol day series to adjust hydrocortisone. [1]
Limitations and use
- Adult numerical stress and crisis doses here must not be extrapolated to children. The full age-specific replacement, paediatric crisis, surgical and obstetric protocols are not reproduced.
- Morning cortisol cutoffs are specified for modern immunoassays; alternative assays and acute illness require appropriate specialist interpretation. This summary does not replace dynamic endocrine testing where indicated.
- Emergency-card schemes, prescription arrangements and named UK services need local equivalents for Indian practice.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Adrenal insufficiency: identification and management
Selected recommendation material consulted
Publication details
- Issuing organisation
- NICE
- First published
- 28 August 2024
- Resource type
- Clinical guideline · House clinical summary
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.